Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-04-21 · accession 0001209191-23-052058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | RXRX | Li Dean Y | Dir | A - Grant | $0.00 | +1,659 | 1.33M | +0.1% | $0 | |
| I | 2023-10-04 | 2023-04-21 | RXRX | Li Dean Y | Dir | G - Gift | $0.00 | -627.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-10-02 | A | A | 1,659 | $0.00 | 1,326,415 | D By Dean Y. Li 2021 GRAT | — | — | (F1) The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. (F2) Reflects 687,295 shares transferred to the Reporting Person from the Dean Y. Li 2021 GRAT |
| 2 | Common | Class A Common Stock | 2023-04-21 | G | D | 627,705 | $0.00 | 0 | I | — | — | (F2) Reflects 687,295 shares transferred to the Reporting Person from the Dean Y. Li 2021 GRAT |